1 |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
5
|
Chang MT...Taylor BS
|
26619011 |
2016 |
2 |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
5
|
MacConaill LE...Lindeman NI
|
25157968 |
2014 |
3 |
Development and characterization of a differentiated thyroid cancer cell line resistant to VEGFR-targeted kinase inhibitors.
5
|
Isham CR...Bible KC
|
24628546 |
2014 |
4 |
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.
5
|
Ho AL...Fagin JA
|
23406027 |
2013 |
5 |
AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines.
5
|
Couto JP...Soares P
|
23056499 |
2012 |
6 |
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
5
|
Wells SA...Schlumberger MJ
|
22025146 |
2012 |
7 |
The effects of four different tyrosine kinase inhibitors on medullary and papillary thyroid cancer cells.
5
|
Verbeek HH...Hofstra RM
|
21470995 |
2011 |
8 |
Targeted therapies for thyroid tumors.
5
|
Sherman SI
|
21455200 |
2011 |
9 |
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.
5
|
Carr LL...Martins RG
|
20847059 |
2010 |
10 |
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.
5
|
Lam ET...Shah MH
|
20368568 |
2010 |
11 |
Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.
5
|
Wells SA...Schlumberger M
|
20065189 |
2010 |
12 |
Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma.
5
|
Hoftijzer H...Smit JW
|
19773371 |
2009 |
13 |
Phase II trial of sorafenib in metastatic thyroid cancer.
5
|
Kloos RT...Shah MH
|
19255327 |
2009 |
14 |
Phase II trial of sorafenib in advanced thyroid cancer.
5
|
Gupta-Abramson V...Brose MS
|
18541894 |
2008 |
15 |
Hyperactive Ras in developmental disorders and cancer.
5
|
Schubbert S...Bollag G
|
17384584 |
2007 |
16 |
Molecular biology of the MEN2 gene.
5
|
Santoro M...Vecchio G
|
9681850 |
1998 |
17 |
Thyroid tuberculosis diagnosed as papillary thyroid carcinoma with fever of unknown origin.
62
|
Kinoshita I...Kawata R
|
34657776 |
2022 |
18 |
Intrathyroidal Thymic Carcinoma: A Retrospective Case Series Study.
62
|
Liang J...Xu H
|
36408572 |
2022 |
19 |
Anesthetic management of trachea with huge thyroid tumor compression: A case report.
62
|
Jin B...Zhang X
|
36456440 |
2022 |
20 |
A Case of Thyroid Carcinoma Showing Thymus-Like Differentiation With Breast Cancer Susceptibility Gene 2 Mutation: A Case Report and Literature Review.
62
|
Kuroki M...Horikawa Y
|
36426335 |
2022 |
21 |
Case Report: Giant Thyroid Angiolipoma-Challenging Clinical Diagnosis and Novel Genetic Alterations.
62
|
Wilkins R...Zhou F
|
36255668 |
2022 |
22 |
Downhill varices in the hypopharynx due to huge thyroid tumor: a case report.
62
|
Nagaoka R...Sugitani I
|
36273906 |
2022 |
23 |
Using the Baidu index to understand Chinese interest in thyroid related diseases.
62
|
Hu Q...Zhang F
|
36229549 |
2022 |
24 |
FBCU-Net: A fine-grained context modeling network using boundary semantic features for medical image segmentation.
62
|
Yu M...Gao J
|
36240598 |
2022 |
25 |
Ferroptosis Inducers in Thyroid Cancer.
62
|
Sekhar KR...Baregamian N
|
36195678 |
2022 |
26 |
A computed tomography-based radiomic nomogram for predicting lymph node metastasis in patients with early-stage papillary thyroid carcinoma.
62
|
Lai L...Wei X
|
34859689 |
2022 |
27 |
[Risk factors for recurrence and survival analysis in locally advanced T4a papillary thyroid carcinoma after R0 resection].
62
|
Chen JM...Shen X
|
36177557 |
2022 |
28 |
Follicular Neoplasm of Thyroid Revisited: Current Differential Diagnosis and the Impact of Molecular Testing.
62
|
Ohori NP...Nishino M
|
36102526 |
2022 |
29 |
Anaplastic thyroid tumor as an embolic source of metastasis.
62
|
Gonzalez Rodriguez P...Palones FJG
|
35936021 |
2022 |
30 |
Thyroid metastasis revealing a lung adenocarcinoma: A case report and review of the literature.
62
|
Elouarith I...Jahid A
|
36055168 |
2022 |
31 |
Subcutaneous axillary primary epithelioid hemangioendothelioma: report of a rare case.
62
|
Niwa T...Seto Y
|
36083389 |
2022 |
32 |
ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.
62
|
Li W...Jiang G
|
36070054 |
2022 |
33 |
Survival-based bioinformatics analysis to identify hub long non-coding RNAs along with lncRNA-miRNA-mRNA network for potential diagnosis/prognosis of thyroid cancer.
62
|
Morovat P...Samadani AA
|
36149574 |
2022 |
34 |
MiR-203a-3p, miR-204-3p, miR-222-3p as useful diagnostic and prognostic tool for thyroid neoplasia spectrum.
62
|
Stojanovic S...Isic Dencic T
|
36103016 |
2022 |
35 |
Safety and Efficacy of Transoral Robotic Thyroidectomy for Thyroid Tumor: A Systematic Review and Meta-Analysis.
62
|
Kang YJ...Hwang SH
|
36077768 |
2022 |
36 |
Assessment of Preoperative TSH Serum Level and Thyroid Cancer Occurrence in Patients with AUS/FLUS Thyroid Nodule Diagnosis.
62
|
Kaliszewski K...Rudnicki J
|
36009464 |
2022 |
37 |
Retraction notice to "Transnasal humidified rapid-insufflation ventilatory exchange can be utilized in tracheal stenosis caused by thyroid tumor" [J. Clin. Anesth. 62(2020) 109727].
62
|
Ueshima H...Otake H
|
35396112 |
2022 |
38 |
Fumarate Hydratase is a Novel Gene for Familial Non-Medullary Thyroid Cancer.
62
|
Alzahrani AS...Al-Hindi H
|
35751867 |
2022 |
39 |
Primary pulmonary epithelioid angiosarcoma with thyroid tumor history: A case report and literature review.
62
|
Yu L...Qian X
|
35761817 |
2022 |
40 |
Nomograms based on preoperative multimodal ultrasound of papillary thyroid carcinoma for predicting central lymph node metastasis.
62
|
Dai Q...Leng X
|
35226156 |
2022 |
41 |
Hypofractionated radiation therapy of a thyroid tumor in a pet raccoon (Procyon lotor).
62
|
Kroncke C...Gardhouse S
|
35784773 |
2022 |
42 |
Towards Optimized Bioavailability of 99mTc-Labeled Barbiturates for Non-invasive Imaging of Matrix Metalloproteinase Activity.
62
|
Honold L...Hermann S
|
34750717 |
2022 |
43 |
Thyroid tumor ratio: Improving the assessment of the impact of size in pediatric thyroid cancer.
62
|
Paik C...Austin J
|
35322489 |
2022 |
44 |
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.
62
|
Hamidi AA...Moghbeli M
|
35659780 |
2022 |
45 |
Extracellular vesicles from thyroid cancer harbor a functional machinery involved in extracellular matrix remodeling.
62
|
Bravo-Miana RDC...Donadio AC
|
35849996 |
2022 |
46 |
Nerve autofluorescence under near-ultraviolet light: cutting-edge technology for intra-operative neural tissue visualization in 17 patients.
62
|
Dip F...Rosenthal RJ
|
34694489 |
2022 |
47 |
Identification of an interactome network between lncRNAs and miRNAs in thyroid cancer reveals SPTY2D1-AS1 as a new tumor suppressor.
62
|
Ramirez-Moya J...Riesco-Eizaguirre G
|
35562181 |
2022 |
48 |
The Implication of X-Linked Genetic Polymorphisms in Susceptibility and Sexual Dimorphism of Cancer.
62
|
Achilla C...Chatzikyriakidou A
|
35489753 |
2022 |
49 |
Use of ultrasonographic shear wave measurements to diagnose thyroid metastasis from breast carcinoma.
62
|
Hoshi M...Sugitani I
|
35644558 |
2022 |
50 |
Giant cervical goiter in Hashimoto's thyroiditis: A case report.
62
|
Tao T...Jing-Dong L
|
35538703 |
2022 |